These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33062724)

  • 1. STK3 Suppresses Ovarian Cancer Progression by Activating NF-
    Wang X; Wang F; Zhang ZG; Yang XM; Zhang R
    J Immunol Res; 2020; 2020():7263602. PubMed ID: 33062724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
    Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
    Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
    He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation.
    Kim G; Bhattarai PY; Lim SC; Kim JY; Choi HS
    Cancer Lett; 2021 Feb; 499():164-174. PubMed ID: 33253791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
    Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
    Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine/Threonine Protein Kinase-3 Promotes Oral Squamous Cell Carcinoma by Activating Ras-MAPK Mediated Cell Cycle Progression.
    Yue L; Xu Y; Lu P
    Int J Gen Med; 2023; 16():3115-3124. PubMed ID: 37496599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
    Yang M; Zou J; Zhu H; Liu S; Wang H; Bai P; Xiao X
    Oncol Rep; 2015 May; 33(5):2190-8. PubMed ID: 25760800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.
    Zhang Y; Wang SS; Tao L; Pang LJ; Zou H; Liang WH; Liu Z; Guo SL; Jiang JF; Zhang WJ; Jia W; Li F
    Sci Rep; 2019 Jun; 9(1):8401. PubMed ID: 31182739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.
    Schirmer AU; Driver LM; Zhao MT; Wells CI; Pickett JE; O'Bryne SN; Eduful BJ; Yang X; Howard L; You S; Devi GR; DiGiovanni J; Freedland SJ; Chi JT; Drewry DH; Macias E
    Mol Ther; 2022 Jan; 30(1):485-500. PubMed ID: 34450249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 13. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
    Zheng B; Geng L; Zeng L; Liu F; Huang Q
    Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFRL1 Promotes Ovarian Cancer Progression by Crosstalk with Hedgehog Signaling.
    Tai H; Wu Z; Sun S; Zhang Z; Xu C
    J Immunol Res; 2018; 2018():7438608. PubMed ID: 29675438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STK3/4 Expression Is Regulated in Uterine Endometrial Cells during the Estrous Cycle.
    Moon S; Lee OH; Lee S; Lee J; Park H; Park M; Chang EM; Park KH; Choi Y
    Cells; 2019 Dec; 8(12):. PubMed ID: 31847471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway.
    Yang W; Liu L; Li C; Luo N; Chen R; Li L; Yu F; Cheng Z
    Cell Death Dis; 2018 Sep; 9(9):908. PubMed ID: 30185771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
    Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
    J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
    Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J
    BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.